$Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?$

Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?

Management of metastatic radioiodine refractory differentiated thyroid cancer (DTC) can be a therapeutic challenge. Generally, little is known about the paired molecular profile of the primary tumor and the metastases and whether they harbor the same genetic abnormalities. The present study compared...

Full description

Bibliographic Details
Main Authors:	Cristiane J. Gomes-Lima, Leila Shobab, Di Wu, Dorina Ylli, Athanasios Bikas, Matthew McCoy, Rebecca Feldman, Wen Lee, Sarika N. Rao, Kirk Jensen, Vasily Vasko, Luiz Claudio Castro, Jacqueline Jonklaas, Leonard Wartofsky, Kenneth D. Burman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Endocrinology
Subjects:	differentiated thyroid cancer metastases radioiodine refractory molecular profile next generation sequencing
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.623182/full

Similar Items

Can Reverse T3 Assay Be Employed to Guide T4 vs. T4/T3 Therapy in Hypothyroidism?
by: Cristiane Gomes-Lima, et al.
Published: (2019-12-01)

Two themes in thyroid cancer: artful diagnosis and shortened lives
by: Cristiane Gomes Lima, et al.

Salivary function after radioiodine therapy: poor correlation between symptoms and salivary scintigraphy
by: Jacqueline eJonklaas
Published: (2015-06-01)

Radioiodine-Labeling of Chlorpyrifos and Its Biodistribution in Mice
by: DIAO Yao, et al.
Published: (2015-11-01)

A Novel Reagent for Radioiodine Labeling of New Chemical Entities (NCEs) and Biomolecules
by: Krishan Kumar, et al.
Published: (2021-07-01)

Uptake and effect of radioiodine exposure on SKBR-3 cell lines
by: Miftah Irramah, et al.
Published: (2019-12-01)

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

Radiation Exposure Levels in Relatives of Patients after Radioiodine Therapy
by: Bererhi H, et al.
Published: (2000-10-01)

Radioiodine-resistant metastases of well-differentiated thyroid cancer, analysis of tumor characteristics and primary surgical intervention
by: M. V. Ostafiychuk, et al.
Published: (2021-10-01)

Cost-effectivness analysis of total thyroidectomy vs radioiodine for Graves disease
by: Prokić Anđelka
Published: (2013-01-01)

Potential of the drug-regulation iodide uptake in patients for prevention of radioiodine-refractory papillary thyroid cancer
by: Dmitriy Kirillovich Fomin, et al.
Published: (2014-11-01)

Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy
by: Kirk Jensen, et al.
Published: (2020-08-01)

Recognition of Radiological Protection of Ward Staff after Brachytherapy for Malignant Tumor with Radioiodine Seeds
by: HU Shu, et al.
Published: (2016-02-01)

Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
by: Arwa Alsaud, et al.
Published: (2020-03-01)

Recombinant human thyrotropin in radioiodine diagnostics and radioiodine ablation of patients with well-differentiated thyroid cancer: the first experience in Russia
by: Ivan I. Dedov, et al.
Published: (2018-12-01)

The history of radioiodine therapy beginnings
by: Pavel Olegovich Rumiantsev, et al.
Published: (2016-03-01)

Effects of Radioiodine Therapy on the Natural History of Graves' Ophtalmopathy
Published: (2007-09-01)

Investigation of a novel modified fixed dose determination protocol for radioiodine treatment of feline hyperthyroidism
by: Wentworth-Morre, Wendy Ann
Published: (2017)

Immobilization of Radioiodine via an Interzeolite Transformation to Iodosodalite
by: Hyejin An, et al.
Published: (2020-10-01)

Prognostic significance of risk factors for thyrotoxicosis development in radioiodine therapy
by: N.B. Ubaydullaeva, et al.
Published: (2020-09-01)

Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism
by: Ardenfors, O., et al.
Published: (2022)

Radioiodine-Labeling of New Small Polypeptide Targeted to Lung Cancer and Its Biodistribution in Mice
by: LI Gui-ping;HUANG Bao-dan;DU Li;HAN Yan-jiang;ZHANG Hui;HUANG Kai;ZHENG Wen-li
Published: (2014-02-01)

The RAI-6 Questionnaire: A New Screening Questionnaire to Monitor Complications of Radioiodine Treatment
by: Samanta Buchholzer, et al.
Published: (2021-09-01)

Correlation of free T4 level at diagnosis and 03, 06 months after fixed dose radioiodine therapy among the hyperthyroid patients
by: Sanooz Raheem, et al.
Published: (2020-08-01)

Outcome of Radioiodine Therapy in a West African Population
by: Yetunde A Onimode, et al.
Published: (2016-01-01)

A tribute to Dr. Saul Hertz: The discovery of the medical uses of radioiodine
by: Barbara Hertz
Published: (2019-01-01)

Effect of amifostine on sperm DNA fragmentation and testes after radioiodine treatment
by: Sen Cigdem Cebi, et al.
Published: (2017-12-01)

Occurrence of symptomatic meningioma as a second neoplasm in patients with differentiated thyroid cancer treated with radioiodine
by: Nishikant Avinash Damle, et al.
Published: (2012-01-01)

Long-term carbimazole pretreatment reduces the efficacy of radioiodine therapy
by: C Shivaprasad, et al.
Published: (2015-01-01)

Efficacy and safety of radioiodine treatment of Graves’ disease in children and adolescents
by: Pavel O. Rumiantsev, et al.
Published: (2017-07-01)

Impact of different approaches to calculation of treatment activities on achieved doses in radioiodine therapy of benign thyroid diseases
by: Jochen Hammes, et al.
Published: (2018-12-01)

Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
by: Erin Fanning, et al.
Published: (2018-12-01)

Radioiodine treatment in McCune-Albright syndrome with hyperthyroidism
by: Dhritiman Chakraborty, et al.
Published: (2012-01-01)

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth
by: Alexandru Mester, et al.
Published: (2021-04-01)

Sudden Development of Subcutaneous Nodules Shortly after Radioiodine Treatment for Thyroid Cancer Caused by Self-Limiting Sarcoidosis
by: Wael Zaher, et al.
Published: (2020-05-01)

Restaging of differentiated thyroid carcinoma with SPECT/CT after radioiodine therapy
by: Mariya Alekseevna Karalkina, et al.
Published: (2015-07-01)

Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer
by: Athanasios Bikas, et al.
Published: (2020-09-01)

Dry Distillation of Radioiodine from TeO2 Targets
by: Jacek Koziorowski, et al.
Published: (2013-10-01)

Improved Patient Dosimetry at Radioiodine Therapy by Combining the ICRP Compartment Model and the EANM Pre-Therapeutic Standard Procedure for Benign Thyroid Diseases
by: Martin Andersson, et al.
Published: (2021-03-01)

Comparison of three methods used for measurement of radioiodine fixation in thyroid gland of mice
by: Jeremić Marija Ž., et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_85moav1olbkks7erelsd3ek6i6